Mortality News and Research

RSS

Methacetin breath test predicts long-term survival in patients with chronic viral hepatitis

A methacetin breath test (MBT) that can be performed quickly and noninvasively has been proven to accurately predict survival in patients with viral hepatitis and may be used as an adjunctive tool to MELD.

2 Nov 2009

Global health organizations observe World Pneumonia Day; urge governments to take steps to fight pneumonia

Nearly 100 leading global health organizations from around the world joined forces to recognize the first-annual World Pneumonia Day on November 2 and urge governments to take steps to fight pneumonia, the world’s leading killer of young children.

2 Nov 2009

MRSA bloodstream infection linked to high mortality rate

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

2 Nov 2009

Dialysis patients with low body fat face high mortality rate

Dialysis patients with low body fat are at increased risk of death-even compared to patients at the highest level of body fat percentage, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego.

2 Nov 2009

Study: Charcoal lessens atherosclerotic lesions in mice with kidney damage

Charcoal may provide a new approach to managing the high rate of heart disease in patients with advanced kidney disease, according to preliminary research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

2 Nov 2009

HCV progresses more rapidly after liver transplantation in African-Americans compared to whites

Previous studies have shown that hepatitis C virus (HCV) progresses slower prior to liver transplantation in African Americans than in whites. However, researchers demonstrate in this study, which will be presented at the annual meeting of the American Association for the Study of Liver Diseases, that the opposite is true after transplantation, in that recurrent HCV in the transplanted liver progresses faster in African Americans than in whites.

1 Nov 2009

Hospitals and medical centers partner to share quality data to improve breast cancer treatment

The Metropolitan Chicago Breast Cancer Task Force has announced the 56 participating hospitals, medical centers and mammography providers that are partnering to share quality data in order to identify deficits and implement strategies to improve breast cancer screening and treatment and reduce breast cancer mortality disparities.

31 Oct 2009

Congressman Mike Thompson lauded for endorsing the Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance (LCA) praised Congressman Mike Thompson (D-CA) for his endorsement of the Lung Cancer Mortality Reduction Act of 2009. Thompson joins Representatives Michael Honda (D-CA), Barbara Lee (D-CA) and Lucille Roybal-Allard (D-CA) in strengthening California's Congressional support for this critically needed legislation.

31 Oct 2009

Amgen publishes Phase 3 study results of Aranesp

Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.

31 Oct 2009

Race of kidney donors may affect the survival rates of transplant recipients

The race of kidney donors may affect the survival rates of transplant recipients according to a study by Henry Ford Hospital.

31 Oct 2009

Study: Gene therapy can reduce symptoms of Huntington's disease

Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

31 Oct 2009

Data from multiple clinical and preclinical studies evaluating Hematide announced

Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients.

31 Oct 2009

Recent releases in Global Health

"Action always leads to reaction, a fundamental law of nature," write the authors of an introduction appearing in a Journal of Acquired Immune Deficiency Syndromes (JAIDS) supplemental issue that focuses on global health systems.

30 Oct 2009

Study: Lack of insurance may have caused 17,000 child deaths over 20 years

"An estimated 17,000 children in the United States might have died unnecessarily over nearly two decades because they didn't have health insurance, according to a report from researchers at Johns Hopkins Children's Center in Baltimore," reports U.S. News and World Report.

30 Oct 2009

130 million children to be immunised against pneumonia

Marking the first international World Pneumonia Day on 2 November, the GAVI Alliance plans to immunise 130 million children in poor countries against pneumonia, the world's leading child killer.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.

30 Oct 2009

MSC's Quality Initiative Programs to support best practice-based training for healthcare professionals

MSC's Sepsis Program has demonstrated the capability to increase tested knowledge in early identification and treatment of sepsis among trainees by over 46 percent. The program has been delivered to healthcare providers representing a range of institutions, from community hospitals to large academic teaching hospitals, demonstrating wide applicability among healthcare professionals with varied clinical backgrounds and previous training.

30 Oct 2009

UNFPA maternal health conferences wrap up

Two United Nations Population Fund (UNFPA) conferences this week in Addis Ababa, Ethiopia, gathered "international policymakers, government ministers, and lawmakers" to address the half a million maternal deaths annually, Radio Free Europe/Radio Liberty reports. Although the U.N. "hopes to reduce maternal mortality by three quarters between 1990 and 2015," this Millennium Development Goal target "has seen the least progress in recent years," the news organization writes.

29 Oct 2009

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

The management of dyslipidemia continues to evolve and despite improvements in recurrent cardiovascular events and a decrease in cardiac mortality, cardiovascular disease (CVD) still represents the major burden of disease in this country.

29 Oct 2009

Mortality News and Research

Methacetin breath test predicts long-term survival in patients with chronic viral hepatitis

Global health organizations observe World Pneumonia Day; urge governments to take steps to fight pneumonia

MRSA bloodstream infection linked to high mortality rate

Dialysis patients with low body fat face high mortality rate

Study: Charcoal lessens atherosclerotic lesions in mice with kidney damage

HCV progresses more rapidly after liver transplantation in African-Americans compared to whites

Hospitals and medical centers partner to share quality data to improve breast cancer treatment

Congressman Mike Thompson lauded for endorsing the Lung Cancer Mortality Reduction Act

Amgen publishes Phase 3 study results of Aranesp

Race of kidney donors may affect the survival rates of transplant recipients

Study: Gene therapy can reduce symptoms of Huntington's disease

Data from multiple clinical and preclinical studies evaluating Hematide announced

Recent releases in Global Health

Study: Lack of insurance may have caused 17,000 child deaths over 20 years

130 million children to be immunised against pneumonia

Eisai reports global Phase III study results of eribulin mesylate

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

MSC's Quality Initiative Programs to support best practice-based training for healthcare professionals

UNFPA maternal health conferences wrap up

CCS updates the Canadian guidelines for the management and treatment of dyslipidemia

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News